Skip to main content
PW Medtech Group Limited logo

PW Medtech Group Limited — Investor Relations & Filings

Ticker · 1358 ISIN · KYG7306W1087 LEI · 894500L18EYHNJR6VJ41 HKEX Manufacturing
Open in API
Filings indexed 789 across all filing types
Latest filing 2016-06-16 Transaction in Own Shar…
Country KY Cayman Islands
Listing HKEX 1358

About PW Medtech Group Limited

http://www.pwmedtech.com

PW Medtech Group Limited is a medical device company engaged in the research, development, production, and sale of advanced infusion therapy products. The company's core portfolio includes specialized infusion sets and related accessories, such as non-PVC and DEHP-free infusion systems, precision filter infusion sets, light-resistant infusion sets, and safety IV catheters. Operating primarily in China, India, the Americas, and Africa, the Group emphasizes patient and clinician safety. Key innovations include positive pressure needleless connectors designed to prevent blood backflow and contamination, and safety-engineered devices utilizing double-layer tubing (TPU/PVC) and high-precision filtration to mitigate needlestick injuries and adverse infusion reactions.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is a disclosure return related to changes in issued share capital and share buybacks by PW Medtech Group Limited. It includes detailed information on share repurchases, dates, quantities, prices, and confirmations of compliance with listing rules. The content focuses on share capital changes and repurchase activities rather than financial results, management changes, or regulatory filings. This matches the description of a Transaction in Own Shares (POS) filing, which reports company buybacks or sales of its own shares. The document length is over 5,000 characters and contains substantive data, so it is not merely an announcement or certification. Therefore, the correct classification is POS.
2016-06-16 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is a Next Day Disclosure Return for a Main Board listed issuer, PW Medtech Group Limited, detailing changes in issued share capital and share buybacks. It includes specific data on share repurchases, dates, prices, and confirmations of compliance with listing rules. The content focuses on reporting share repurchase transactions and changes in issued shares, which aligns with announcements regarding share buybacks or capital changes. It is not a full financial report, earnings release, or management discussion. The document is not a report publication announcement but a detailed disclosure of share capital changes and repurchases. Therefore, the appropriate classification is 'Transaction in Own Shares' (POS).
2016-06-15 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is a disclosure return related to changes in issued share capital and share buybacks by PW Medtech Group Limited. It includes detailed information on share repurchases, dates, quantities, and prices, as well as confirmations that the repurchases comply with listing rules. The document is structured as a regulatory disclosure form for share capital changes and share buybacks, not a full financial report or earnings release. It does not contain financial statements or management discussion but focuses on capital changes and repurchase activities. Therefore, it fits the category of Transaction in Own Shares (POS), which covers reports of the company buying back or selling its own shares.
2016-06-14 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is a disclosure return related to changes in issued share capital and share buybacks by PW Medtech Group Limited. It includes detailed information on share repurchases, dates, prices, and confirmations that the repurchases comply with listing rules. The document is regulatory in nature, reporting share capital changes and share buybacks, which aligns with the category for Transaction in Own Shares (POS). It is not an announcement of a report, nor a full financial report, but a regulatory disclosure of share transactions by the company itself. Therefore, the appropriate classification is POS.
2016-06-13 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MAY 2016
Major Shareholding Notification Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31/05/2016, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorized and issued share capital, including share options, warrants, convertibles, and other share capital changes. The content focuses on share capital changes and movements rather than financial performance, earnings, or management commentary. It is a regulatory filing reporting share capital movements for a specific month, consistent with a Major Shareholding Notification or similar capital movement report. Given the detailed share capital movement data and the monthly reporting nature, the document fits best under the category Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership or share capital movements. The document is not an announcement of a report, nor a full financial report, nor a management or board change announcement. Therefore, the classification is MRQ with high confidence.
2016-06-03 English
Next Day Disclosure Return
Share Issue/Capital Change Classification · 100% confidence The document is a disclosure return related to changes in issued share capital and share buybacks by PW Medtech Group Limited. It includes detailed information on share repurchases, dates, prices, and compliance with listing rules. The content focuses on reporting share capital changes and share repurchase transactions, which aligns with announcements regarding share issues or capital changes. It is not a full financial report, earnings release, or management discussion. The document is not a report publication announcement or a certification but a regulatory disclosure of share capital changes and buybacks. Therefore, the appropriate classification is Share Issue/Capital Change (SHA).
2016-06-01 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.